The store will not work correctly when cookies are disabled.
5-hydroxy-2-[3-(m-tolyl)propyl]chromen-4-one
ID: ALA4763861
PubChem CID: 162660908
Max Phase: Preclinical
Molecular Formula: C19H18O3
Molecular Weight: 294.35
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: Cc1cccc(CCCc2cc(=O)c3c(O)cccc3o2)c1
Standard InChI: InChI=1S/C19H18O3/c1-13-5-2-6-14(11-13)7-3-8-15-12-17(21)19-16(20)9-4-10-18(19)22-15/h2,4-6,9-12,20H,3,7-8H2,1H3
Standard InChI Key: VWUGVHZBVPDCAO-UHFFFAOYSA-N
Molfile:
RDKit 2D
22 24 0 0 0 0 0 0 0 0999 V2000
12.1491 -3.8342 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.1480 -4.6537 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.8560 -5.0627 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.8543 -3.4253 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.5629 -3.8306 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.5617 -4.6557 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.2718 -5.0671 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.9876 -4.6578 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.9888 -3.8326 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.2742 -3.4167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.2742 -2.5995 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
12.8518 -2.6081 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
15.6942 -5.0684 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.4030 -4.6618 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.1096 -5.0724 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.8184 -4.6658 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.5222 -5.0793 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.2306 -4.6734 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.2333 -3.8553 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.5218 -3.4449 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.8163 -3.8532 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.9369 -5.0843 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
5 10 1 0
6 7 1 0
7 8 1 0
8 9 2 0
9 10 1 0
10 11 2 0
4 12 1 0
8 13 1 0
13 14 1 0
14 15 1 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 16 1 0
18 22 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 294.35 | Molecular Weight (Monoisotopic): 294.1256 | AlogP: 3.98 | #Rotatable Bonds: 4 |
Polar Surface Area: 50.44 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 3 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 7.46 | CX Basic pKa: ┄ | CX LogP: 5.28 | CX LogD: 5.01 |
Aromatic Rings: 3 | Heavy Atoms: 22 | QED Weighted: 0.79 | Np Likeness Score: 0.64 |
References
1. Kim M,Truss M,Pagare PP,Essandoh MA,Zhang Y,Williams DA. (2020) Structure activity relationship exploration of 5-hydroxy-2-(3-phenylpropyl)chromones as a unique 5-HT receptor antagonist scaffold., 30 (21.0): [PMID:32853682] [10.1016/j.bmcl.2020.127511] |